imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce

NARecruitingINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 7, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension
Interventions
BEHAVIORAL

Telemedicine-Based Adherence Support

The intervention consists of biweekly teleconsultations for six months, conducted by healthcare professionals, focusing on medication adherence, patient education, side effect management, and remote support for individuals with pulmonary arterial hypertension (PAH). Patients will receive structured guidance on treatment adherence, tailored counseling, and real-time problem-solving strategies. The goal is to improve adherence to oral PAH therapy and enhance clinical outcomes compared to standard care.

Trial Locations (1)

05048000

RECRUITING

InCor - Universidade de São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT06850792 - imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce | Biotech Hunter | Biotech Hunter